Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Sep 8, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.1K

布因通过调节PDE4/cAMP/p-CREB通路,缓解了白缺乏的小鼠的非酒精性脂肪肝炎

Chao Guo1,2, Yushan Zhang2, Huan Xue2

  • 1Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, People's Republic of China.

Drug design, development and therapy
|August 20, 2025
PubMed
概括

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Machine Learning Unveils Dietary Antioxidants as Influential Factors for Diabetes-Cancer Comorbidity: Insights From National Health and Nutrition Examination Survey.

Food science & nutrition·2026
Same author

The causal relationship between cathepsins and ankylosing spondylitis: a two-sample Mendelian randomization study.

Therapeutic advances in musculoskeletal disease·2026
Same author

Empagliflozin Attenuates Liver Inflammation and Fibrosis in NAFLD: Evidence from Mendelian Randomization and Mouse Experiments.

Current issues in molecular biology·2025
Same author

Visceral Fat Area and Subcutaneous Fat Area Increase in Hyperthyroidism Patients After Treatment-A Single-Group Repeated-Measures Trial.

Diabetes, metabolic syndrome and obesity : targets and therapy·2024
Same author

Association of Aldosterone, Renin, and Aldosterone to Renin Ratio with Metabolic Profile in Primary Aldosteronism.

Diabetes, metabolic syndrome and obesity : targets and therapy·2024
Same author

Uric Acid Metabolic Disorders in Pituitary-Target Gland Axis.

Diabetes, metabolic syndrome and obesity : targets and therapy·2024

在治疗非酒精性脂肪肝炎 (NASH) 方面,布丁具有前景. 通过调节PDE4/cAMP/p-CREB通路,这种黄素可以降低小鼠模型中的肝炎和纤维化.

科学领域:

  • 肝病学
  • 药理学
  • 分子生物学

背景情况:

  • 非酒精性脂肪肝炎 (NASH) 是一种日益严重的肝病,治疗方案有限.
  • 与布丁蛋白一样, 类蛋白具有抗炎和抗氧化作用.
  • 在NASH治疗中,布因的治疗潜力在很大程度上尚未被探索.

研究的目的:

  • 在NASH实验模型中研究布丁蛋白的治疗效果.
  • 阐明在NASH中布丁蛋白作用的分子机制.
  • 评估布丁蛋白对葡萄脂代谢,炎症和纤维化的影响.

主要方法:

  • 使用GAN饮食诱导的NASH缺乏叶黄素 (ob/ob) 的小鼠模型.
  • 使用使用棕酸处理的HepG2和LX-2细胞的体外模型.
  • 评估了氧化应激,炎症,纤维化标志物和PDE4/cAMP/p-CREB通路.

主要成果:

  • 在小鼠中,布因显著改善了葡萄脂代谢,减少了肝炎,改善了肝纤维化.
  • 在实验室中,丁氨酸减弱了HepG2细胞中的棕酸诱导的氧化应激.
  • 布丁减少了LX-2细胞的炎症和纤维反应.
关键词:
纤维化炎症的发生脂质新陈代谢非酒精性脂肪肝疾病

更多相关视频

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.0K
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.0K

相关实验视频

Last Updated: Sep 8, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.1K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

1.0K
Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.0K

结论:

  • 布丁蛋白对NASH的进展具有保护作用.
  • PDE4/cAMP/p-CREB信号通路与布丁的治疗作用有关.
  • 布丁是NASH的潜在治疗候选药物,需要进一步的临床研究.